Charles Russell Speechlys advises Kreos Capital V (UK) Limited on senior secured loan to Pharming Group NV
Charles Russell Speechlys LLP advised Kreos Capital V (UK) Limited (“Kreos”) on its €21 million senior secured loan to Pharming Group NV (“Pharming”) and its subscription for €6 million subordinated redeemable convertible bond issued by Pharming.
The transaction is part of a larger fundraising exercise carried out by Pharming to raise €104 million before costs (comprising of straight debt, convertible bonds and proceeds of rights issue) to, amongst others, acquire all commercialisation rights to its own product RUCONEST® in North America and to repay its existing debt facility.
The Charles Russell Speechlys core team comprised Corporate Partner Chris Putt, Corporate Associates Rossana Conti and Amelly Kok and Banking Partner Daniel Sullivan.
News & Insights
TMT Connect Newsletter - July 2019
Welcome to the latest edition of our TMT Connect Newsletter.
Motion Marks - The new moving trademarks and guidance for non-traditional trade mark applicants
The UK Intellectual Property Office has recently granted the first multimedia moving trade mark.
Charles Russell Speechlys advises Puma Property Finance
This transaction further builds on Puma Property Finance’s extensive activity in the retirement living sector.